CVMAX
Price
$28.82
Change
+$0.15 (+0.52%)
Updated
Jul 8 closing price
Net Assets
1.74B
RNWHX
Price
$105.77
Change
+$0.94 (+0.90%)
Updated
Jul 9 closing price
Net Assets
90.88B
Interact to see
Advertisement

CVMAX vs RNWHX

CVMAX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
CVMAX vs. RNWHX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVMAX is a Hold and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90.9B vs. CVMAX (1.74B). CVMAX pays higher dividends than RNWHX: CVMAX (1.57) vs RNWHX (1.14). CVMAX was incepted earlier than RNWHX: CVMAX (14 years) vs RNWHX (11 years). CVMAX (1.34) is less costly to investors than RNWHX (0.72). CVMAX is a more actively managed with annual turnover of: 67.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than CVMAX: RNWHX (250) vs CVMAX (1000). CVMAX annual gain was more profitable for investors over the last year : 48.17 vs. RNWHX (20.29). CVMAX return over 5 years is better than : 35.09 vs. RNWHX (16.12).
CVMAXRNWHXCVMAX / RNWHX
Total Expense Ratio1.240.72172%
Annual Report Gross Expense Ratio1.340.72186%
Fund Existence14 years11 years-
Gain YTD26.34814.032188%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B90.9B2%
Annual Yield % from dividends1.571.14137%
Returns for 1 year48.1720.29237%
Returns for 3 years84.5850.36168%
Returns for 5 years35.0916.12218%
Returns for 10 years157.23113.35139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTEX20.410.48
+2.41%
ICON Health and Information Tech Instl
NAMAX17.44N/A
N/A
Columbia Select Mid Cap Value Instl
MYIMX27.47N/A
N/A
Victory Integrity Mid-Cap Value Y
PIDIX15.22N/A
N/A
Principal International EQ Index Instl
FCGSX33.15N/A
N/A
Fidelity Series Growth Company